

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | indole-containing compound catabolic process (GO:0042436) | 5.94955983 |
| 2 | indolalkylamine catabolic process (GO:0046218) | 5.94955983 |
| 3 | tryptophan catabolic process (GO:0006569) | 5.94955983 |
| 4 | kynurenine metabolic process (GO:0070189) | 5.87204131 |
| 5 | intestinal absorption (GO:0050892) | 5.63906961 |
| 6 | intestinal cholesterol absorption (GO:0030299) | 5.62687031 |
| 7 | indolalkylamine metabolic process (GO:0006586) | 5.59934225 |
| 8 | cilium or flagellum-dependent cell motility (GO:0001539) | 5.42003696 |
| 9 | angiotensin maturation (GO:0002003) | 5.05535587 |
| 10 | response to misfolded protein (GO:0051788) | 4.99557014 |
| 11 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.92391169 |
| 12 | tryptophan metabolic process (GO:0006568) | 4.87967746 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.75372947 |
| 14 | positive regulation of developmental pigmentation (GO:0048087) | 4.75156732 |
| 15 | regulation of pigment cell differentiation (GO:0050932) | 4.62296867 |
| 16 | regulation of hippo signaling (GO:0035330) | 4.61150172 |
| 17 | epoxygenase P450 pathway (GO:0019373) | 4.58650354 |
| 18 | protein K48-linked deubiquitination (GO:0071108) | 4.55282089 |
| 19 | regulation of posttranscriptional gene silencing (GO:0060147) | 4.43017542 |
| 20 | regulation of gene silencing by miRNA (GO:0060964) | 4.43017542 |
| 21 | regulation of gene silencing by RNA (GO:0060966) | 4.43017542 |
| 22 | drug catabolic process (GO:0042737) | 4.35390537 |
| 23 | NAD biosynthetic process (GO:0009435) | 4.30002375 |
| 24 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 4.26810163 |
| 25 | indole-containing compound metabolic process (GO:0042430) | 4.23820088 |
| 26 | photoreceptor cell maintenance (GO:0045494) | 4.21446370 |
| 27 | regulation of bile acid biosynthetic process (GO:0070857) | 4.21268383 |
| 28 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.20405183 |
| 29 | negative regulation of protein localization to cell surface (GO:2000009) | 4.19459232 |
| 30 | cellular ketone body metabolic process (GO:0046950) | 4.16240072 |
| 31 | regulation of sarcomere organization (GO:0060297) | 4.09011937 |
| 32 | oxidative demethylation (GO:0070989) | 4.07861114 |
| 33 | reflex (GO:0060004) | 4.04714429 |
| 34 | high-density lipoprotein particle remodeling (GO:0034375) | 4.03700572 |
| 35 | endosome to melanosome transport (GO:0035646) | 4.02809365 |
| 36 | endosome to pigment granule transport (GO:0043485) | 4.02809365 |
| 37 | negative regulation of sodium ion transport (GO:0010766) | 3.95505068 |
| 38 | serotonin metabolic process (GO:0042428) | 3.94525503 |
| 39 | snRNA transcription (GO:0009301) | 3.93663759 |
| 40 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.92906261 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 3.91598554 |
| 42 | reverse cholesterol transport (GO:0043691) | 3.91251962 |
| 43 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.91159352 |
| 44 | cholesterol efflux (GO:0033344) | 3.90960443 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 3.87884048 |
| 46 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.82291304 |
| 47 | phospholipid efflux (GO:0033700) | 3.81993747 |
| 48 | detection of light stimulus involved in visual perception (GO:0050908) | 3.77405006 |
| 49 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.77405006 |
| 50 | glomerulus development (GO:0032835) | 3.73160959 |
| 51 | lipoprotein metabolic process (GO:0042157) | 3.72773537 |
| 52 | cellular biogenic amine catabolic process (GO:0042402) | 3.70438193 |
| 53 | amine catabolic process (GO:0009310) | 3.70438193 |
| 54 | flavonoid metabolic process (GO:0009812) | 3.67482553 |
| 55 | * signal peptide processing (GO:0006465) | 3.67272515 |
| 56 | gamma-aminobutyric acid transport (GO:0015812) | 3.64773326 |
| 57 | ketone body metabolic process (GO:1902224) | 3.63578414 |
| 58 | plasma lipoprotein particle assembly (GO:0034377) | 3.61946969 |
| 59 | phospholipid translocation (GO:0045332) | 3.59126202 |
| 60 | lipid translocation (GO:0034204) | 3.59126202 |
| 61 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.59069913 |
| 62 | primary amino compound metabolic process (GO:1901160) | 3.58230637 |
| 63 | alkaloid metabolic process (GO:0009820) | 3.57754160 |
| 64 | C21-steroid hormone biosynthetic process (GO:0006700) | 3.57194194 |
| 65 | plasma lipoprotein particle remodeling (GO:0034369) | 3.51168423 |
| 66 | protein-lipid complex remodeling (GO:0034368) | 3.51168423 |
| 67 | macromolecular complex remodeling (GO:0034367) | 3.51168423 |
| 68 | membrane depolarization during action potential (GO:0086010) | 3.48996489 |
| 69 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.48475871 |
| 70 | neural tube formation (GO:0001841) | 3.41908596 |
| 71 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.41124526 |
| 72 | nucleobase catabolic process (GO:0046113) | 3.40211198 |
| 73 | glyoxylate metabolic process (GO:0046487) | 3.39211373 |
| 74 | positive regulation of lipid catabolic process (GO:0050996) | 3.39008201 |
| 75 | auditory receptor cell stereocilium organization (GO:0060088) | 3.37096486 |
| 76 | protein-lipid complex assembly (GO:0065005) | 3.36637147 |
| 77 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.35036411 |
| 78 | regulation of establishment of cell polarity (GO:2000114) | 3.34085895 |
| 79 | cholesterol homeostasis (GO:0042632) | 3.34038310 |
| 80 | retinal cone cell development (GO:0046549) | 3.33902624 |
| 81 | glucocorticoid biosynthetic process (GO:0006704) | 3.33842189 |
| 82 | urea metabolic process (GO:0019627) | 3.33630993 |
| 83 | urea cycle (GO:0000050) | 3.33630993 |
| 84 | adhesion of symbiont to host (GO:0044406) | 3.32566002 |
| 85 | dicarboxylic acid catabolic process (GO:0043649) | 3.32044285 |
| 86 | sterol homeostasis (GO:0055092) | 3.31862765 |
| 87 | fucose catabolic process (GO:0019317) | 3.30970897 |
| 88 | L-fucose metabolic process (GO:0042354) | 3.30970897 |
| 89 | L-fucose catabolic process (GO:0042355) | 3.30970897 |
| 90 | sterol transport (GO:0015918) | 3.30051704 |
| 91 | cholesterol transport (GO:0030301) | 3.30051704 |
| 92 | tachykinin receptor signaling pathway (GO:0007217) | 3.27806227 |
| 93 | alpha-linolenic acid metabolic process (GO:0036109) | 3.27086438 |
| 94 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.25804038 |
| 95 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.25804038 |
| 96 | striated muscle atrophy (GO:0014891) | 3.25410037 |
| 97 | one-carbon compound transport (GO:0019755) | 3.25173802 |
| 98 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 3.24739809 |
| 99 | glucocorticoid metabolic process (GO:0008211) | 3.22487450 |
| 100 | homocysteine metabolic process (GO:0050667) | 3.21930374 |
| 101 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.21127585 |
| 102 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.21127585 |
| 103 | negative regulation of cholesterol transport (GO:0032375) | 3.20661436 |
| 104 | negative regulation of sterol transport (GO:0032372) | 3.20661436 |
| 105 | thyroid hormone metabolic process (GO:0042403) | 3.20284665 |
| 106 | plasma lipoprotein particle clearance (GO:0034381) | 3.19584619 |
| 107 | protein K63-linked deubiquitination (GO:0070536) | 3.18730345 |
| 108 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.18250149 |
| 109 | negative regulation of complement activation (GO:0045916) | 3.17136361 |
| 110 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.16630288 |
| 111 | hormone catabolic process (GO:0042447) | 3.16606934 |
| 112 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.16060417 |
| 113 | triglyceride homeostasis (GO:0070328) | 3.15230944 |
| 114 | acylglycerol homeostasis (GO:0055090) | 3.15230944 |
| 115 | nonmotile primary cilium assembly (GO:0035058) | 3.10685318 |
| 116 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 3.10404319 |
| 117 | cellular response to sterol (GO:0036315) | 3.09929193 |
| 118 | exogenous drug catabolic process (GO:0042738) | 3.08466352 |
| 119 | neuronal action potential (GO:0019228) | 3.07746774 |
| 120 | vitamin A metabolic process (GO:0006776) | 3.07217169 |
| 121 | limb development (GO:0060173) | 3.05186923 |
| 122 | appendage development (GO:0048736) | 3.05186923 |
| 123 | low-density lipoprotein particle clearance (GO:0034383) | 3.04592547 |
| 124 | drug metabolic process (GO:0017144) | 3.02789322 |
| 125 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 3.01355324 |
| 126 | regulation of female gonad development (GO:2000194) | 3.01186060 |
| 127 | bile acid and bile salt transport (GO:0015721) | 2.99859083 |
| 128 | response to phenylpropanoid (GO:0080184) | 2.99705557 |
| 129 | regulation of cholesterol homeostasis (GO:2000188) | 2.96438204 |
| 130 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.96148955 |
| 131 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.95335097 |
| 132 | nitrogen cycle metabolic process (GO:0071941) | 2.95284896 |
| 133 | androgen biosynthetic process (GO:0006702) | 2.93982416 |
| 134 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.92365908 |
| 135 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.92141538 |
| 136 | behavioral response to ethanol (GO:0048149) | 2.90932940 |
| 137 | skeletal muscle adaptation (GO:0043501) | 2.90913782 |
| 138 | postsynaptic membrane organization (GO:0001941) | 2.90845695 |
| 139 | estrogen biosynthetic process (GO:0006703) | 2.90243895 |
| 140 | midgut development (GO:0007494) | 2.89713586 |
| 141 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.88923421 |
| 142 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.87756614 |
| 143 | L-phenylalanine catabolic process (GO:0006559) | 2.87756614 |
| 144 | behavioral response to nicotine (GO:0035095) | 2.86962248 |
| 145 | plasma lipoprotein particle organization (GO:0071827) | 2.86492103 |
| 146 | ovulation cycle (GO:0042698) | 2.85578122 |
| 147 | mesonephros development (GO:0001823) | 2.83639679 |
| 148 | righting reflex (GO:0060013) | 2.83346647 |
| 149 | cellular modified amino acid catabolic process (GO:0042219) | 2.82176163 |
| 150 | bile acid biosynthetic process (GO:0006699) | 2.81645174 |
| 151 | aromatic amino acid family metabolic process (GO:0009072) | 2.80029120 |
| 152 | transmission of nerve impulse (GO:0019226) | 2.79182874 |
| 153 | L-phenylalanine metabolic process (GO:0006558) | 2.79002879 |
| 154 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.79002879 |
| 155 | negative regulation of mast cell activation (GO:0033004) | 2.78820481 |
| 156 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.78247704 |
| 157 | protein carboxylation (GO:0018214) | 2.78247704 |
| 158 | negative regulation of protein activation cascade (GO:2000258) | 2.77861403 |
| 159 | benzene-containing compound metabolic process (GO:0042537) | 2.77052561 |
| 160 | phospholipid homeostasis (GO:0055091) | 2.76955182 |
| 161 | protein-lipid complex subunit organization (GO:0071825) | 2.76664134 |
| 162 | sulfation (GO:0051923) | 2.76596387 |
| 163 | interkinetic nuclear migration (GO:0022027) | 2.76484338 |
| 164 | bile acid metabolic process (GO:0008206) | 2.73960838 |
| 165 | positive regulation of fatty acid oxidation (GO:0046321) | 2.73274062 |
| 166 | cilium movement (GO:0003341) | 2.72537820 |
| 167 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.71680038 |
| 168 | muscle atrophy (GO:0014889) | 2.71240865 |
| 169 | protein targeting to lysosome (GO:0006622) | 2.70863695 |
| 170 | establishment of protein localization to vacuole (GO:0072666) | 2.70863695 |
| 171 | protein targeting to vacuole (GO:0006623) | 2.70863695 |
| 172 | lysine metabolic process (GO:0006553) | 2.68335556 |
| 173 | lysine catabolic process (GO:0006554) | 2.68335556 |
| 174 | lipoprotein transport (GO:0042953) | 2.68092539 |
| 175 | cellular glucuronidation (GO:0052695) | 2.66638492 |
| 176 | metanephric mesenchyme development (GO:0072075) | 2.66279004 |
| 177 | regulation of protein activation cascade (GO:2000257) | 2.66040952 |
| 178 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.65231185 |
| 179 | adhesion of symbiont to host cell (GO:0044650) | 2.64692226 |
| 180 | virion attachment to host cell (GO:0019062) | 2.64692226 |
| 181 | complement activation, alternative pathway (GO:0006957) | 2.63168604 |
| 182 | aromatic amino acid family catabolic process (GO:0009074) | 2.62358052 |
| 183 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.61744857 |
| 184 | protein heterotrimerization (GO:0070208) | 2.61504957 |
| 185 | cellular response to cadmium ion (GO:0071276) | 2.61483467 |
| 186 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.60330125 |
| 187 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.58704495 |
| 188 | lipid homeostasis (GO:0055088) | 2.58497818 |
| 189 | drug transmembrane transport (GO:0006855) | 2.58156249 |
| 190 | endocardial cushion development (GO:0003197) | 2.54511353 |
| 191 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.54064174 |
| 192 | regulation of complement activation (GO:0030449) | 2.53575584 |
| 193 | negative regulation of fibrinolysis (GO:0051918) | 2.53261037 |
| 194 | cysteine metabolic process (GO:0006534) | 2.51630331 |
| 195 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.48092330 |
| 196 | C21-steroid hormone metabolic process (GO:0008207) | 2.47602631 |
| 197 | response to follicle-stimulating hormone (GO:0032354) | 2.47173869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.36538842 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.68597315 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 3.54416266 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.26630089 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.22071736 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.08867160 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.97157912 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.82342132 |
| 9 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.71346386 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.51718261 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.45406286 |
| 12 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.43589222 |
| 13 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.38842406 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.31274347 |
| 15 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.18050233 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.16982039 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.16026444 |
| 18 | * STAT3_23295773_ChIP-Seq_U87_Human | 2.09586433 |
| 19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.05145930 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.03844010 |
| 21 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.03341306 |
| 22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.00507796 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.95238641 |
| 24 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.91851410 |
| 25 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.91648222 |
| 26 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.90113148 |
| 27 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.88283341 |
| 28 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.85571357 |
| 29 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.85505060 |
| 30 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.83818865 |
| 31 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.80809404 |
| 32 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.80704540 |
| 33 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.80704540 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.80612963 |
| 35 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.79819465 |
| 36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.76918648 |
| 37 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.74325180 |
| 38 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.73804741 |
| 39 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.73804741 |
| 40 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.73032336 |
| 41 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.70917241 |
| 42 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.68355797 |
| 43 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.66008479 |
| 44 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.64284710 |
| 45 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.59539276 |
| 46 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.58840377 |
| 47 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.46917158 |
| 48 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.46319295 |
| 49 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.44209095 |
| 50 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.42987312 |
| 51 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.42987312 |
| 52 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.40469282 |
| 53 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.40427525 |
| 54 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.39985571 |
| 55 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.38870789 |
| 56 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.37996695 |
| 57 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.33291416 |
| 58 | EWS_26573619_Chip-Seq_HEK293_Human | 1.33229225 |
| 59 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.33121898 |
| 60 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.32920952 |
| 61 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.32268146 |
| 62 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.32268146 |
| 63 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.32094717 |
| 64 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.31906695 |
| 65 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.30925684 |
| 66 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.30432802 |
| 67 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.30351527 |
| 68 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.29532876 |
| 69 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.29393127 |
| 70 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.29221698 |
| 71 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.27745351 |
| 72 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.26048933 |
| 73 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.26030682 |
| 74 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25776914 |
| 75 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.25606205 |
| 76 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24166670 |
| 77 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.24037682 |
| 78 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.22892170 |
| 79 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.21921229 |
| 80 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.21464741 |
| 81 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20581541 |
| 82 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20495286 |
| 83 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.19544329 |
| 84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.19254852 |
| 85 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.18945334 |
| 86 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.17681017 |
| 87 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.17107537 |
| 88 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.16816050 |
| 89 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.15911318 |
| 90 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.15662445 |
| 91 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15564610 |
| 92 | RXR_22108803_ChIP-Seq_LS180_Human | 1.15095844 |
| 93 | CJUN_26792858_Chip-Seq_BT549_Human | 1.14926221 |
| 94 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14772957 |
| 95 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.12933553 |
| 96 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12354530 |
| 97 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12176499 |
| 98 | * AR_19668381_ChIP-Seq_PC3_Human | 1.11937492 |
| 99 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.11161972 |
| 100 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.10832424 |
| 101 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.10832424 |
| 102 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10744621 |
| 103 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.10510582 |
| 104 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.10332278 |
| 105 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09997905 |
| 106 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09972759 |
| 107 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.09868973 |
| 108 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.09511303 |
| 109 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.08956690 |
| 110 | FUS_26573619_Chip-Seq_HEK293_Human | 1.08613421 |
| 111 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08567171 |
| 112 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.08549339 |
| 113 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.07994106 |
| 114 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.07401201 |
| 115 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.07226016 |
| 116 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06561710 |
| 117 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06204334 |
| 118 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05865313 |
| 119 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.05772072 |
| 120 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.05454671 |
| 121 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.05325154 |
| 122 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.04944943 |
| 123 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.03986003 |
| 124 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.03420219 |
| 125 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.03198563 |
| 126 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.02659122 |
| 127 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02025919 |
| 128 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.01672222 |
| 129 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.01084427 |
| 130 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.00420817 |
| 131 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.00166213 |
| 132 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99823660 |
| 133 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.99129978 |
| 134 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.98636666 |
| 135 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.98442284 |
| 136 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98430407 |
| 137 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98414001 |
| 138 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98325509 |
| 139 | P300_19829295_ChIP-Seq_ESCs_Human | 0.97457708 |
| 140 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.97296587 |
| 141 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.97074400 |
| 142 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96288633 |
| 143 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.96142529 |
| 144 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.96056860 |
| 145 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.95758559 |
| 146 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95390618 |
| 147 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.93677972 |
| 148 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93458190 |
| 149 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93414128 |
| 150 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.92888283 |
| 151 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.92306198 |
| 152 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.91117133 |
| 153 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.90049564 |
| 154 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.89785848 |
| 155 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.89614174 |
| 156 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.88845621 |
| 157 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.88818620 |
| 158 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.87421609 |
| 159 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.87279910 |
| 160 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.85233202 |
| 161 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84646981 |
| 162 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.84149654 |
| 163 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.82338382 |
| 164 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.82157157 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.46705751 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.34748898 |
| 3 | MP0001501_abnormal_sleep_pattern | 3.95777821 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.87846169 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.72793955 |
| 6 | MP0003646_muscle_fatigue | 3.61549351 |
| 7 | MP0008057_abnormal_DNA_replication | 3.58067438 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 3.58019445 |
| 9 | MP0000569_abnormal_digit_pigmentation | 3.48707634 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.45361275 |
| 11 | MP0003252_abnormal_bile_duct | 3.43574005 |
| 12 | MP0005365_abnormal_bile_salt | 3.33404557 |
| 13 | MP0002736_abnormal_nociception_after | 3.02757701 |
| 14 | MP0005503_abnormal_tendon_morphology | 2.92483553 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.90885947 |
| 16 | MP0005551_abnormal_eye_electrophysiolog | 2.86540711 |
| 17 | MP0009046_muscle_twitch | 2.83667264 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 2.80743657 |
| 19 | MP0001968_abnormal_touch/_nociception | 2.78025464 |
| 20 | MP0003136_yellow_coat_color | 2.65524996 |
| 21 | MP0010368_abnormal_lymphatic_system | 2.40690383 |
| 22 | MP0005275_abnormal_skin_tensile | 2.30191844 |
| 23 | MP0001986_abnormal_taste_sensitivity | 2.25277177 |
| 24 | MP0000383_abnormal_hair_follicle | 2.24291406 |
| 25 | MP0005670_abnormal_white_adipose | 2.22816396 |
| 26 | MP0009384_cardiac_valve_regurgitation | 2.18597675 |
| 27 | MP0005423_abnormal_somatic_nervous | 2.12414110 |
| 28 | MP0004130_abnormal_muscle_cell | 2.11251401 |
| 29 | MP0004272_abnormal_basement_membrane | 2.10896697 |
| 30 | MP0003880_abnormal_central_pattern | 2.06209110 |
| 31 | MP0009745_abnormal_behavioral_response | 2.03657484 |
| 32 | MP0006276_abnormal_autonomic_nervous | 2.01501278 |
| 33 | MP0003950_abnormal_plasma_membrane | 1.95696795 |
| 34 | MP0000427_abnormal_hair_cycle | 1.91561583 |
| 35 | MP0004145_abnormal_muscle_electrophysio | 1.91405748 |
| 36 | MP0005253_abnormal_eye_physiology | 1.86339255 |
| 37 | MP0001486_abnormal_startle_reflex | 1.78730497 |
| 38 | MP0004019_abnormal_vitamin_homeostasis | 1.78050271 |
| 39 | MP0005310_abnormal_salivary_gland | 1.77308829 |
| 40 | MP0003195_calcinosis | 1.73930673 |
| 41 | MP0001485_abnormal_pinna_reflex | 1.71751804 |
| 42 | MP0008961_abnormal_basal_metabolism | 1.70575429 |
| 43 | MP0009840_abnormal_foam_cell | 1.69762199 |
| 44 | MP0001970_abnormal_pain_threshold | 1.69043800 |
| 45 | MP0005332_abnormal_amino_acid | 1.68619629 |
| 46 | MP0005167_abnormal_blood-brain_barrier | 1.67077915 |
| 47 | MP0006054_spinal_hemorrhage | 1.59585932 |
| 48 | MP0001984_abnormal_olfaction | 1.58928646 |
| 49 | MP0002733_abnormal_thermal_nociception | 1.57827551 |
| 50 | MP0008872_abnormal_physiological_respon | 1.55031593 |
| 51 | MP0009780_abnormal_chondrocyte_physiolo | 1.52544128 |
| 52 | MP0002064_seizures | 1.52186825 |
| 53 | MP0010234_abnormal_vibrissa_follicle | 1.51821291 |
| 54 | MP0003045_fibrosis | 1.50533884 |
| 55 | MP0000462_abnormal_digestive_system | 1.49774236 |
| 56 | MP0002272_abnormal_nervous_system | 1.47286760 |
| 57 | MP0000537_abnormal_urethra_morphology | 1.46680079 |
| 58 | MP0005266_abnormal_metabolism | 1.45307852 |
| 59 | MP0002735_abnormal_chemical_nociception | 1.44920292 |
| 60 | MP0002653_abnormal_ependyma_morphology | 1.43428118 |
| 61 | MP0004142_abnormal_muscle_tone | 1.42898205 |
| 62 | MP0005084_abnormal_gallbladder_morpholo | 1.42781817 |
| 63 | MP0002572_abnormal_emotion/affect_behav | 1.39864862 |
| 64 | MP0002638_abnormal_pupillary_reflex | 1.32071638 |
| 65 | MP0003879_abnormal_hair_cell | 1.31767004 |
| 66 | MP0003633_abnormal_nervous_system | 1.30719992 |
| 67 | MP0002067_abnormal_sensory_capabilities | 1.29989281 |
| 68 | MP0000534_abnormal_ureter_morphology | 1.29790402 |
| 69 | MP0009764_decreased_sensitivity_to | 1.26776058 |
| 70 | MP0000639_abnormal_adrenal_gland | 1.26062519 |
| 71 | MP0002118_abnormal_lipid_homeostasis | 1.24896907 |
| 72 | MP0009697_abnormal_copulation | 1.23977523 |
| 73 | MP0002734_abnormal_mechanical_nocicepti | 1.23039432 |
| 74 | MP0003941_abnormal_skin_development | 1.19035683 |
| 75 | * MP0003385_abnormal_body_wall | 1.15917990 |
| 76 | MP0005646_abnormal_pituitary_gland | 1.13382290 |
| 77 | MP0003191_abnormal_cellular_cholesterol | 1.12894709 |
| 78 | MP0003183_abnormal_peptide_metabolism | 1.11100731 |
| 79 | MP0004264_abnormal_extraembryonic_tissu | 1.11001656 |
| 80 | MP0005647_abnormal_sex_gland | 1.10852940 |
| 81 | MP0005174_abnormal_tail_pigmentation | 1.10234541 |
| 82 | MP0005367_renal/urinary_system_phenotyp | 1.09151309 |
| 83 | MP0000516_abnormal_urinary_system | 1.09151309 |
| 84 | MP0005248_abnormal_Harderian_gland | 1.08542964 |
| 85 | MP0005645_abnormal_hypothalamus_physiol | 1.07432277 |
| 86 | MP0004043_abnormal_pH_regulation | 1.06610100 |
| 87 | MP0006138_congestive_heart_failure | 1.05569742 |
| 88 | MP0005257_abnormal_intraocular_pressure | 1.04259419 |
| 89 | MP0002295_abnormal_pulmonary_circulatio | 1.03783737 |
| 90 | MP0002557_abnormal_social/conspecific_i | 1.03443641 |
| 91 | MP0001879_abnormal_lymphatic_vessel | 1.02966098 |
| 92 | MP0010678_abnormal_skin_adnexa | 1.02354023 |
| 93 | MP0001963_abnormal_hearing_physiology | 1.02222611 |
| 94 | MP0003631_nervous_system_phenotype | 1.01619059 |
| 95 | MP0005410_abnormal_fertilization | 1.01382814 |
| 96 | MP0005448_abnormal_energy_balance | 1.01352663 |
| 97 | MP0003635_abnormal_synaptic_transmissio | 1.00888222 |
| 98 | MP0002095_abnormal_skin_pigmentation | 1.00489897 |
| 99 | MP0003942_abnormal_urinary_system | 0.99881230 |
| 100 | MP0002229_neurodegeneration | 0.99352268 |
| 101 | MP0000609_abnormal_liver_physiology | 0.98263931 |
| 102 | MP0001958_emphysema | 0.95645665 |
| 103 | * MP0003115_abnormal_respiratory_system | 0.95295187 |
| 104 | MP0002254_reproductive_system_inflammat | 0.95242114 |
| 105 | MP0002332_abnormal_exercise_endurance | 0.94710548 |
| 106 | MP0009643_abnormal_urine_homeostasis | 0.94700641 |
| 107 | MP0002108_abnormal_muscle_morphology | 0.94595462 |
| 108 | * MP0000538_abnormal_urinary_bladder | 0.94151351 |
| 109 | MP0000230_abnormal_systemic_arterial | 0.94108234 |
| 110 | MP0010386_abnormal_urinary_bladder | 0.93800307 |
| 111 | MP0005319_abnormal_enzyme/_coenzyme | 0.93187409 |
| 112 | MP0002876_abnormal_thyroid_physiology | 0.92725135 |
| 113 | MP0006082_CNS_inflammation | 0.92022846 |
| 114 | MP0002090_abnormal_vision | 0.91413531 |
| 115 | * MP0009053_abnormal_anal_canal | 0.91122258 |
| 116 | MP0002060_abnormal_skin_morphology | 0.90227440 |
| 117 | MP0005386_behavior/neurological_phenoty | 0.88507365 |
| 118 | MP0004924_abnormal_behavior | 0.88507365 |
| 119 | MP0003632_abnormal_nervous_system | 0.87825490 |
| 120 | MP0005171_absent_coat_pigmentation | 0.87822617 |
| 121 | MP0003122_maternal_imprinting | 0.86023224 |
| 122 | MP0002138_abnormal_hepatobiliary_system | 0.85557369 |
| 123 | MP0005508_abnormal_skeleton_morphology | 0.84604019 |
| 124 | MP0002896_abnormal_bone_mineralization | 0.82534196 |
| 125 | MP0005195_abnormal_posterior_eye | 0.79670145 |
| 126 | MP0003718_maternal_effect | 0.79208675 |
| 127 | MP0003698_abnormal_male_reproductive | 0.78405352 |
| 128 | MP0000470_abnormal_stomach_morphology | 0.78386918 |
| 129 | MP0003300_gastrointestinal_ulcer | 0.77954145 |
| 130 | MP0002063_abnormal_learning/memory/cond | 0.77951395 |
| 131 | MP0004883_abnormal_blood_vessel | 0.77758214 |
| 132 | * MP0009250_abnormal_appendicular_skeleto | 0.77683771 |
| 133 | MP0002249_abnormal_larynx_morphology | 0.77669562 |
| 134 | MP0002089_abnormal_postnatal_growth/wei | 0.77516539 |
| 135 | MP0008775_abnormal_heart_ventricle | 0.77324903 |
| 136 | MP0004036_abnormal_muscle_relaxation | 0.76892411 |
| 137 | MP0000371_diluted_coat_color | 0.76879334 |
| 138 | MP0005377_hearing/vestibular/ear_phenot | 0.76732773 |
| 139 | MP0003878_abnormal_ear_physiology | 0.76732773 |
| 140 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75815516 |
| 141 | MP0009379_abnormal_foot_pigmentation | 0.75461925 |
| 142 | MP0002837_dystrophic_cardiac_calcinosis | 0.74800513 |
| 143 | MP0000566_synostosis | 0.74446876 |
| 144 | MP0005636_abnormal_mineral_homeostasis | 0.72372887 |
| 145 | MP0002168_other_aberrant_phenotype | 0.71634984 |
| 146 | MP0004233_abnormal_muscle_weight | 0.71098470 |
| 147 | MP0000767_abnormal_smooth_muscle | 0.71080983 |
| 148 | MP0004742_abnormal_vestibular_system | 0.70796814 |
| 149 | MP0000467_abnormal_esophagus_morphology | 0.69871144 |
| 150 | MP0004215_abnormal_myocardial_fiber | 0.69633861 |
| 151 | MP0004147_increased_porphyrin_level | 0.69169126 |
| 152 | MP0003279_aneurysm | 0.67623386 |
| 153 | MP0001664_abnormal_digestion | 0.67187083 |
| 154 | MP0002928_abnormal_bile_duct | 0.66987339 |
| 155 | MP0002882_abnormal_neuron_morphology | 0.66585867 |
| 156 | MP0001177_atelectasis | 0.66431464 |
| 157 | MP0001756_abnormal_urination | 0.66380202 |
| 158 | MP0003638_abnormal_response/metabolism_ | 0.65956127 |
| 159 | MP0001765_abnormal_ion_homeostasis | 0.64255870 |
| 160 | MP0000163_abnormal_cartilage_morphology | 0.62864267 |
| 161 | MP0005381_digestive/alimentary_phenotyp | 0.59250924 |
| 162 | MP0002971_abnormal_brown_adipose | 0.59245598 |
| 163 | MP0009115_abnormal_fat_cell | 0.58486335 |
| 164 | MP0005595_abnormal_vascular_smooth | 0.58321493 |
| 165 | MP0005623_abnormal_meninges_morphology | 0.58181370 |
| 166 | MP0000049_abnormal_middle_ear | 0.56211580 |
| 167 | MP0002822_catalepsy | 0.55868128 |
| 168 | MP0002796_impaired_skin_barrier | 0.55668177 |
| 169 | MP0002909_abnormal_adrenal_gland | 0.55173015 |
| 170 | MP0005334_abnormal_fat_pad | 0.55106857 |
| 171 | MP0010030_abnormal_orbit_morphology | 0.54736823 |
| 172 | MP0005187_abnormal_penis_morphology | 0.54415658 |
| 173 | MP0000579_abnormal_nail_morphology | 0.54258581 |
| 174 | * MP0002115_abnormal_skeleton_extremities | 0.54042659 |
| 175 | MP0004484_altered_response_of | 0.52857950 |
| 176 | MP0002282_abnormal_trachea_morphology | 0.51462305 |
| 177 | MP0005023_abnormal_wound_healing | 0.50735017 |
| 178 | MP0001764_abnormal_homeostasis | 0.50512939 |
| 179 | MP0003091_abnormal_cell_migration | 0.48939760 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Genetic anticipation (HP:0003743) | 6.53620776 |
| 2 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 6.24892039 |
| 3 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 6.15673133 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 5.45383640 |
| 5 | Abnormality of binocular vision (HP:0011514) | 5.33466617 |
| 6 | Diplopia (HP:0000651) | 5.33466617 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.32413957 |
| 8 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.16679586 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.67225497 |
| 10 | Protrusio acetabuli (HP:0003179) | 4.63602776 |
| 11 | Pancreatic cysts (HP:0001737) | 4.49308958 |
| 12 | Gaze-evoked nystagmus (HP:0000640) | 4.44197896 |
| 13 | Premature rupture of membranes (HP:0001788) | 4.17532137 |
| 14 | Ileus (HP:0002595) | 4.15220762 |
| 15 | Xanthomatosis (HP:0000991) | 4.14715591 |
| 16 | Clumsiness (HP:0002312) | 4.11561246 |
| 17 | Hypolipoproteinemia (HP:0010981) | 3.95217093 |
| 18 | Abnormality of proline metabolism (HP:0010907) | 3.93838771 |
| 19 | Hydroxyprolinuria (HP:0003080) | 3.93838771 |
| 20 | Attenuation of retinal blood vessels (HP:0007843) | 3.89386715 |
| 21 | Hyperventilation (HP:0002883) | 3.81121978 |
| 22 | Epidermoid cyst (HP:0200040) | 3.76792819 |
| 23 | Pancreatic fibrosis (HP:0100732) | 3.73661893 |
| 24 | Acanthocytosis (HP:0001927) | 3.69788824 |
| 25 | Conjugated hyperbilirubinemia (HP:0002908) | 3.66700091 |
| 26 | Dysmetric saccades (HP:0000641) | 3.63065144 |
| 27 | Deep venous thrombosis (HP:0002625) | 3.59585862 |
| 28 | True hermaphroditism (HP:0010459) | 3.55971819 |
| 29 | Intrahepatic cholestasis (HP:0001406) | 3.46276008 |
| 30 | Right ventricular cardiomyopathy (HP:0011663) | 3.45971143 |
| 31 | Protruding tongue (HP:0010808) | 3.39755505 |
| 32 | Congenital stationary night blindness (HP:0007642) | 3.39576542 |
| 33 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 3.32067331 |
| 34 | Mesangial abnormality (HP:0001966) | 3.29342695 |
| 35 | Central scotoma (HP:0000603) | 3.26756951 |
| 36 | Congenital sensorineural hearing impairment (HP:0008527) | 3.25399141 |
| 37 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.24050317 |
| 38 | Medial flaring of the eyebrow (HP:0010747) | 3.23776534 |
| 39 | Malnutrition (HP:0004395) | 3.23176863 |
| 40 | Fat malabsorption (HP:0002630) | 3.20588692 |
| 41 | Potter facies (HP:0002009) | 3.19232568 |
| 42 | Facial shape deformation (HP:0011334) | 3.19232568 |
| 43 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.17560223 |
| 44 | Cystic liver disease (HP:0006706) | 3.14491544 |
| 45 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.10853224 |
| 46 | Broad metatarsal (HP:0001783) | 3.05396610 |
| 47 | Abolished electroretinogram (ERG) (HP:0000550) | 3.05275462 |
| 48 | Gait imbalance (HP:0002141) | 3.05122102 |
| 49 | Congenital primary aphakia (HP:0007707) | 3.01920341 |
| 50 | Large for gestational age (HP:0001520) | 3.01678839 |
| 51 | Hypoalphalipoproteinemia (HP:0003233) | 2.92274325 |
| 52 | Pigmentary retinal degeneration (HP:0001146) | 2.88084830 |
| 53 | Facial diplegia (HP:0001349) | 2.86759870 |
| 54 | Fragile skin (HP:0001030) | 2.83092122 |
| 55 | Hyperglycinuria (HP:0003108) | 2.81688087 |
| 56 | Soft skin (HP:0000977) | 2.79904724 |
| 57 | Abnormality of the ischium (HP:0003174) | 2.78641525 |
| 58 | Hemiplegia (HP:0002301) | 2.78176813 |
| 59 | Hypoplastic ischia (HP:0003175) | 2.74880489 |
| 60 | Aortic dissection (HP:0002647) | 2.74848325 |
| 61 | Chronic hepatic failure (HP:0100626) | 2.72150783 |
| 62 | Hemiparesis (HP:0001269) | 2.69303756 |
| 63 | Skin nodule (HP:0200036) | 2.68844898 |
| 64 | Molar tooth sign on MRI (HP:0002419) | 2.68389717 |
| 65 | Abnormality of midbrain morphology (HP:0002418) | 2.68389717 |
| 66 | Focal segmental glomerulosclerosis (HP:0000097) | 2.68057189 |
| 67 | Nephrogenic diabetes insipidus (HP:0009806) | 2.65566336 |
| 68 | Atrophic scars (HP:0001075) | 2.65492955 |
| 69 | Hypercholesterolemia (HP:0003124) | 2.65405932 |
| 70 | Abnormality of alanine metabolism (HP:0010916) | 2.60186740 |
| 71 | Hyperalaninemia (HP:0003348) | 2.60186740 |
| 72 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.60186740 |
| 73 | Abnormality of the renal cortex (HP:0011035) | 2.59935077 |
| 74 | Enlarged penis (HP:0000040) | 2.56924173 |
| 75 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.53441102 |
| 76 | Complement deficiency (HP:0004431) | 2.53156792 |
| 77 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.51334117 |
| 78 | Hepatoblastoma (HP:0002884) | 2.51128529 |
| 79 | Lymphangioma (HP:0100764) | 2.50199494 |
| 80 | Peritonitis (HP:0002586) | 2.48819970 |
| 81 | Shallow orbits (HP:0000586) | 2.47009647 |
| 82 | Vaginal atresia (HP:0000148) | 2.45475607 |
| 83 | Abnormality of purine metabolism (HP:0004352) | 2.44278388 |
| 84 | Abnormality of glycine metabolism (HP:0010895) | 2.42480767 |
| 85 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.42480767 |
| 86 | Genital tract atresia (HP:0001827) | 2.42423778 |
| 87 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.41359676 |
| 88 | Widely patent fontanelles and sutures (HP:0004492) | 2.40679220 |
| 89 | Decreased circulating renin level (HP:0003351) | 2.40135279 |
| 90 | Sclerocornea (HP:0000647) | 2.39948369 |
| 91 | Nephronophthisis (HP:0000090) | 2.39637398 |
| 92 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.38944759 |
| 93 | Birth length less than 3rd percentile (HP:0003561) | 2.38871936 |
| 94 | Broad foot (HP:0001769) | 2.38323767 |
| 95 | Focal seizures (HP:0007359) | 2.37773682 |
| 96 | Dialeptic seizures (HP:0011146) | 2.35248448 |
| 97 | Preaxial foot polydactyly (HP:0001841) | 2.33986970 |
| 98 | Inability to walk (HP:0002540) | 2.32839968 |
| 99 | Rectal prolapse (HP:0002035) | 2.32275347 |
| 100 | Progressive visual loss (HP:0000529) | 2.32254526 |
| 101 | Poor coordination (HP:0002370) | 2.30614403 |
| 102 | Abnormality of the renal medulla (HP:0100957) | 2.30043844 |
| 103 | Mitral valve prolapse (HP:0001634) | 2.26878244 |
| 104 | Tubular atrophy (HP:0000092) | 2.26319116 |
| 105 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.25744338 |
| 106 | Furrowed tongue (HP:0000221) | 2.25655205 |
| 107 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.25627226 |
| 108 | Hyperammonemia (HP:0001987) | 2.25024949 |
| 109 | Abnormal biliary tract physiology (HP:0012439) | 2.24626359 |
| 110 | Bile duct proliferation (HP:0001408) | 2.24626359 |
| 111 | Abnormal drinking behavior (HP:0030082) | 2.23774980 |
| 112 | Polydipsia (HP:0001959) | 2.23774980 |
| 113 | Increased corneal curvature (HP:0100692) | 2.22024026 |
| 114 | Keratoconus (HP:0000563) | 2.22024026 |
| 115 | Cardiovascular calcification (HP:0011915) | 2.20072012 |
| 116 | Impaired smooth pursuit (HP:0007772) | 2.19919262 |
| 117 | Absent speech (HP:0001344) | 2.19625773 |
| 118 | Absence seizures (HP:0002121) | 2.18404188 |
| 119 | Wide anterior fontanel (HP:0000260) | 2.18388869 |
| 120 | Fair hair (HP:0002286) | 2.18361894 |
| 121 | Turricephaly (HP:0000262) | 2.17576472 |
| 122 | Congenital, generalized hypertrichosis (HP:0004540) | 2.15727418 |
| 123 | Neonatal short-limb short stature (HP:0008921) | 2.15604625 |
| 124 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.15361389 |
| 125 | Congenital hepatic fibrosis (HP:0002612) | 2.15231784 |
| 126 | Abnormal ciliary motility (HP:0012262) | 2.15188049 |
| 127 | Glomerulosclerosis (HP:0000096) | 2.14085811 |
| 128 | Mitral stenosis (HP:0001718) | 2.13870430 |
| 129 | Ankle contracture (HP:0006466) | 2.13461761 |
| 130 | Nephrolithiasis (HP:0000787) | 2.13160119 |
| 131 | Scotoma (HP:0000575) | 2.10996801 |
| 132 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.09423326 |
| 133 | Progressive inability to walk (HP:0002505) | 2.09353416 |
| 134 | Coronal craniosynostosis (HP:0004440) | 2.09328287 |
| 135 | Patellar aplasia (HP:0006443) | 2.09306895 |
| 136 | Short foot (HP:0001773) | 2.07831973 |
| 137 | Aortic aneurysm (HP:0004942) | 2.06314423 |
| 138 | Postural instability (HP:0002172) | 2.05436903 |
| 139 | Chorioretinal atrophy (HP:0000533) | 2.05433737 |
| 140 | Prolonged partial thromboplastin time (HP:0003645) | 2.05267333 |
| 141 | Decreased central vision (HP:0007663) | 2.05149582 |
| 142 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.03410286 |
| 143 | Abnormal delivery (HP:0001787) | 2.03030407 |
| 144 | Cerebellar dysplasia (HP:0007033) | 2.02490849 |
| 145 | Biconcave vertebral bodies (HP:0004586) | 2.01741243 |
| 146 | Enlarged kidneys (HP:0000105) | 2.00364812 |
| 147 | Abnormality of the common coagulation pathway (HP:0010990) | 2.00226193 |
| 148 | Febrile seizures (HP:0002373) | 1.99637502 |
| 149 | Hyperextensible skin (HP:0000974) | 1.99253374 |
| 150 | Difficulty walking (HP:0002355) | 1.97391818 |
| 151 | Dysautonomia (HP:0002459) | 1.96284201 |
| 152 | Nonimmune hydrops fetalis (HP:0001790) | 1.95671626 |
| 153 | Bladder diverticulum (HP:0000015) | 1.94855337 |
| 154 | Increased mean platelet volume (HP:0011877) | 1.94762194 |
| 155 | Absent/shortened dynein arms (HP:0200106) | 1.93795969 |
| 156 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.93795969 |
| 157 | Type II lissencephaly (HP:0007260) | 1.93318896 |
| 158 | Abnormal cartilage morphology (HP:0002763) | 1.93162336 |
| 159 | Retinitis pigmentosa (HP:0000510) | 1.92216063 |
| 160 | Increased connective tissue (HP:0009025) | 1.90661932 |
| 161 | Constricted visual fields (HP:0001133) | 1.87764333 |
| 162 | Atonic seizures (HP:0010819) | 1.87389345 |
| 163 | Nephritis (HP:0000123) | 1.87218916 |
| 164 | Abnormality of complement system (HP:0005339) | 1.85437927 |
| 165 | Retinal dysplasia (HP:0007973) | 1.85191105 |
| 166 | Abnormality of nucleobase metabolism (HP:0010932) | 1.84114945 |
| 167 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.83141257 |
| 168 | Wide cranial sutures (HP:0010537) | 1.82808891 |
| 169 | Cupped ribs (HP:0000887) | 1.82508681 |
| 170 | Shawl scrotum (HP:0000049) | 1.82340143 |
| 171 | Overgrowth (HP:0001548) | 1.82147988 |
| 172 | Abnormality of the pubic bones (HP:0003172) | 1.81600362 |
| 173 | Gastrointestinal dysmotility (HP:0002579) | 1.81136980 |
| 174 | Ketoacidosis (HP:0001993) | 1.80607152 |
| 175 | Vascular calcification (HP:0004934) | 1.80154088 |
| 176 | Poikilocytosis (HP:0004447) | 1.79491989 |
| 177 | Poikiloderma (HP:0001029) | 1.78927737 |
| 178 | Hypopigmentation of the fundus (HP:0007894) | 1.78667730 |
| 179 | Left ventricular hypertrophy (HP:0001712) | 1.78239545 |
| 180 | Progressive sensorineural hearing impairment (HP:0000408) | 1.77273587 |
| 181 | Alopecia of scalp (HP:0002293) | 1.74549121 |
| 182 | Spontaneous abortion (HP:0005268) | 1.73103444 |
| 183 | Bronchomalacia (HP:0002780) | 1.71679608 |
| 184 | Follicular hyperkeratosis (HP:0007502) | 1.71580812 |
| 185 | Hepatocellular carcinoma (HP:0001402) | 1.70844408 |
| 186 | Ketosis (HP:0001946) | 1.69773429 |
| 187 | Hyperuricemia (HP:0002149) | 1.67484389 |
| 188 | Increased purine levels (HP:0004368) | 1.67484389 |
| 189 | Blue sclerae (HP:0000592) | 1.67480104 |
| 190 | Ectopia lentis (HP:0001083) | 1.66037716 |
| 191 | Hyperlipoproteinemia (HP:0010980) | 1.66000420 |
| 192 | Cerebral aneurysm (HP:0004944) | 1.65825238 |
| 193 | Hypoglycemic coma (HP:0001325) | 1.65542925 |
| 194 | Dilatation of the ascending aorta (HP:0005111) | 1.65414849 |
| 195 | Abdominal distention (HP:0003270) | 1.62818422 |
| 196 | Hyperaldosteronism (HP:0000859) | 1.62195486 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.98681760 |
| 2 | EPHB2 | 3.92457438 |
| 3 | LMTK2 | 3.89105136 |
| 4 | AKT3 | 3.77501699 |
| 5 | ACVR1B | 3.23008247 |
| 6 | LATS1 | 2.65905292 |
| 7 | MST1R | 2.65176848 |
| 8 | BMPR1B | 2.64324221 |
| 9 | ADRBK2 | 2.61588873 |
| 10 | RIPK1 | 2.37226995 |
| 11 | DDR2 | 2.08661540 |
| 12 | LATS2 | 2.07955598 |
| 13 | FER | 1.96196667 |
| 14 | NUAK1 | 1.96146631 |
| 15 | SIK1 | 1.91879768 |
| 16 | ERN1 | 1.88099829 |
| 17 | MYLK | 1.74579593 |
| 18 | PDGFRA | 1.74445595 |
| 19 | PRKG2 | 1.68198043 |
| 20 | EPHA3 | 1.67748937 |
| 21 | MAP3K4 | 1.64392149 |
| 22 | MKNK2 | 1.58832387 |
| 23 | TNK2 | 1.55370853 |
| 24 | PTK2B | 1.55196435 |
| 25 | PTK6 | 1.54643571 |
| 26 | TRIB3 | 1.54013694 |
| 27 | PIK3CA | 1.51334945 |
| 28 | CASK | 1.50993185 |
| 29 | DAPK2 | 1.47347573 |
| 30 | GRK1 | 1.40055161 |
| 31 | MAP2K4 | 1.36896146 |
| 32 | MET | 1.31729708 |
| 33 | INSRR | 1.30312160 |
| 34 | PTK2 | 1.25932969 |
| 35 | PLK2 | 1.24879609 |
| 36 | TIE1 | 1.24119486 |
| 37 | MAP2K7 | 1.21104932 |
| 38 | MST4 | 1.16608317 |
| 39 | BMX | 1.13472752 |
| 40 | NME1 | 1.11734805 |
| 41 | MAP3K7 | 1.06224216 |
| 42 | ERBB4 | 1.06039319 |
| 43 | TAOK3 | 1.05367858 |
| 44 | SIK2 | 1.05042067 |
| 45 | ERBB2 | 1.04466355 |
| 46 | ZAK | 1.02377008 |
| 47 | NEK9 | 1.00596807 |
| 48 | FGFR4 | 0.99757661 |
| 49 | WNK4 | 0.97783456 |
| 50 | FGFR2 | 0.96210599 |
| 51 | PAK3 | 0.93382776 |
| 52 | NEK2 | 0.92904134 |
| 53 | STK38L | 0.92353482 |
| 54 | GRK6 | 0.92166645 |
| 55 | PKN1 | 0.90336026 |
| 56 | DMPK | 0.89013881 |
| 57 | TGFBR1 | 0.87490983 |
| 58 | MAP3K2 | 0.86524060 |
| 59 | STK38 | 0.85479349 |
| 60 | MAP3K6 | 0.84917862 |
| 61 | FGFR1 | 0.81313378 |
| 62 | MAP3K9 | 0.79306415 |
| 63 | MAPK13 | 0.77843521 |
| 64 | PRKAA2 | 0.76856875 |
| 65 | SGK3 | 0.76633422 |
| 66 | TRPM7 | 0.75666482 |
| 67 | CAMK1D | 0.75636882 |
| 68 | MAP3K10 | 0.75468982 |
| 69 | ROCK1 | 0.75291902 |
| 70 | NEK6 | 0.71900785 |
| 71 | TEC | 0.71729195 |
| 72 | MINK1 | 0.70644503 |
| 73 | SGK2 | 0.69811463 |
| 74 | KIT | 0.67110943 |
| 75 | NTRK3 | 0.66987374 |
| 76 | OXSR1 | 0.66976191 |
| 77 | KSR1 | 0.66786176 |
| 78 | PAK4 | 0.66535565 |
| 79 | PKN2 | 0.66247390 |
| 80 | PDK2 | 0.65902810 |
| 81 | MAP2K1 | 0.64499191 |
| 82 | DYRK1B | 0.63759394 |
| 83 | MAP4K2 | 0.63681844 |
| 84 | RET | 0.63308284 |
| 85 | PINK1 | 0.61999508 |
| 86 | CDK12 | 0.61788283 |
| 87 | MKNK1 | 0.59835255 |
| 88 | CAMK1G | 0.56624503 |
| 89 | PRKCE | 0.56394817 |
| 90 | ITK | 0.55791182 |
| 91 | MAP3K12 | 0.54405852 |
| 92 | CAMK1 | 0.54339067 |
| 93 | PDGFRB | 0.54287890 |
| 94 | MAPKAPK3 | 0.53909393 |
| 95 | STK3 | 0.53703272 |
| 96 | BCKDK | 0.53415891 |
| 97 | IKBKB | 0.52833040 |
| 98 | WNK3 | 0.52279204 |
| 99 | BRAF | 0.52162211 |
| 100 | LIMK1 | 0.52054840 |
| 101 | PDK1 | 0.50576541 |
| 102 | KSR2 | 0.48464398 |
| 103 | MUSK | 0.47984286 |
| 104 | CHUK | 0.46979954 |
| 105 | MAPK11 | 0.45491227 |
| 106 | SGK494 | 0.45212014 |
| 107 | SGK223 | 0.45212014 |
| 108 | TXK | 0.44311508 |
| 109 | RPS6KA6 | 0.43766721 |
| 110 | EPHA4 | 0.43157460 |
| 111 | BCR | 0.42083583 |
| 112 | MELK | 0.41902062 |
| 113 | PRKCZ | 0.41812054 |
| 114 | SRC | 0.41578911 |
| 115 | NTRK2 | 0.41186335 |
| 116 | PRKCG | 0.40772315 |
| 117 | MARK1 | 0.39575398 |
| 118 | EEF2K | 0.39305769 |
| 119 | PIK3CG | 0.38476068 |
| 120 | GSK3A | 0.38061126 |
| 121 | PDPK1 | 0.37888340 |
| 122 | SIK3 | 0.37292328 |
| 123 | CAMK2A | 0.36688794 |
| 124 | PRKCH | 0.35864855 |
| 125 | ADRBK1 | 0.35258575 |
| 126 | MAPK7 | 0.35144529 |
| 127 | TYRO3 | 0.34822005 |
| 128 | PRKACG | 0.34801353 |
| 129 | CDC42BPA | 0.34501792 |
| 130 | TAOK1 | 0.33106476 |
| 131 | RPS6KA5 | 0.33081110 |
| 132 | PRKAA1 | 0.32198258 |
| 133 | CSNK1D | 0.32099871 |
| 134 | BTK | 0.31233760 |
| 135 | MAPKAPK5 | 0.31035124 |
| 136 | PRKACB | 0.30947969 |
| 137 | PRKD3 | 0.30734579 |
| 138 | IGF1R | 0.28823470 |
| 139 | IRAK1 | 0.28530095 |
| 140 | STK39 | 0.28404419 |
| 141 | BLK | 0.28392789 |
| 142 | PRKACA | 0.28154495 |
| 143 | CDK19 | 0.28009701 |
| 144 | CAMK4 | 0.27919233 |
| 145 | PRKCA | 0.27279872 |
| 146 | CHEK2 | 0.26961654 |
| 147 | PDK3 | 0.26875433 |
| 148 | PDK4 | 0.26875433 |
| 149 | JAK1 | 0.25858469 |
| 150 | SGK1 | 0.25622532 |
| 151 | CAMKK1 | 0.24572394 |
| 152 | RPS6KA3 | 0.24254866 |
| 153 | SYK | 0.24092749 |
| 154 | TLK1 | 0.23896691 |
| 155 | PRKCB | 0.23362221 |
| 156 | MAPK1 | 0.23252410 |
| 157 | GSK3B | 0.22151352 |
| 158 | LCK | 0.22137001 |
| 159 | OBSCN | 0.22040520 |
| 160 | PRKCQ | 0.21684577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.35072543 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.63577920 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.61595977 |
| 4 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.46943093 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.32679955 |
| 6 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.31902116 |
| 7 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.27056432 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.25897016 |
| 9 | Nicotine addiction_Homo sapiens_hsa05033 | 2.23743982 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.22580791 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.17865697 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.15562534 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.15094155 |
| 14 | Bile secretion_Homo sapiens_hsa04976 | 2.08467571 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 2.06037075 |
| 16 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.04739393 |
| 17 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.98948671 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.98690239 |
| 19 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.97508600 |
| 20 | Olfactory transduction_Homo sapiens_hsa04740 | 1.96519229 |
| 21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.87237240 |
| 22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.79145376 |
| 23 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.77761990 |
| 24 | Taste transduction_Homo sapiens_hsa04742 | 1.76994527 |
| 25 | Mineral absorption_Homo sapiens_hsa04978 | 1.74040974 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.70062858 |
| 27 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.68990780 |
| 28 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.66090096 |
| 29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.64131092 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.62771556 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.61364720 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.61021272 |
| 33 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.60476048 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.58954037 |
| 35 | Morphine addiction_Homo sapiens_hsa05032 | 1.57445256 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.52650827 |
| 37 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.44341285 |
| 38 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.41440414 |
| 39 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.38755710 |
| 40 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.36396237 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.35675719 |
| 42 | Galactose metabolism_Homo sapiens_hsa00052 | 1.35390618 |
| 43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.34914634 |
| 44 | Homologous recombination_Homo sapiens_hsa03440 | 1.34886343 |
| 45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.33697647 |
| 46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.32736092 |
| 47 | Circadian entrainment_Homo sapiens_hsa04713 | 1.30412666 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 1.29143167 |
| 49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.28295293 |
| 50 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.27981510 |
| 51 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.26442083 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.24159659 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.22006877 |
| 54 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.21931296 |
| 55 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.21842181 |
| 56 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.18060032 |
| 57 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.16114709 |
| 58 | GABAergic synapse_Homo sapiens_hsa04727 | 1.12473660 |
| 59 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.12376622 |
| 60 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.11402096 |
| 61 | Retinol metabolism_Homo sapiens_hsa00830 | 1.07270342 |
| 62 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.03999651 |
| 63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.01436661 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.01078403 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.99894457 |
| 66 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.99864483 |
| 67 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.99841290 |
| 68 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.97432415 |
| 69 | Lysine degradation_Homo sapiens_hsa00310 | 0.96866046 |
| 70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.96822272 |
| 71 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96658770 |
| 72 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.96350267 |
| 73 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.94729235 |
| 74 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.93978407 |
| 75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92272516 |
| 76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.90414015 |
| 77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.90230296 |
| 78 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.90018006 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.87944281 |
| 80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86465188 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84693429 |
| 82 | Carbon metabolism_Homo sapiens_hsa01200 | 0.82380882 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77534800 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.75425287 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72047560 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.70470704 |
| 87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.69915870 |
| 88 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.69815380 |
| 89 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.69567638 |
| 90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.69513188 |
| 91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68247974 |
| 92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.67868388 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65208048 |
| 94 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65073361 |
| 95 | Insulin secretion_Homo sapiens_hsa04911 | 0.62788909 |
| 96 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.61149033 |
| 97 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61147928 |
| 98 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.60401538 |
| 99 | Renin secretion_Homo sapiens_hsa04924 | 0.59473640 |
| 100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56738379 |
| 101 | Long-term depression_Homo sapiens_hsa04730 | 0.54906132 |
| 102 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.54804749 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53900838 |
| 104 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53621620 |
| 105 | Asthma_Homo sapiens_hsa05310 | 0.53367892 |
| 106 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53330220 |
| 107 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.50980115 |
| 108 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.50651344 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50214254 |
| 110 | Lysosome_Homo sapiens_hsa04142 | 0.49737353 |
| 111 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.48477697 |
| 112 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47766298 |
| 113 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.47710135 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | 0.43721377 |
| 115 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.42877192 |
| 116 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41690024 |
| 117 | Focal adhesion_Homo sapiens_hsa04510 | 0.41242171 |
| 118 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.37390100 |
| 119 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37025969 |
| 120 | Amoebiasis_Homo sapiens_hsa05146 | 0.36820347 |
| 121 | Axon guidance_Homo sapiens_hsa04360 | 0.36754340 |
| 122 | Platelet activation_Homo sapiens_hsa04611 | 0.36427830 |
| 123 | Adherens junction_Homo sapiens_hsa04520 | 0.35431222 |
| 124 | Tight junction_Homo sapiens_hsa04530 | 0.35006828 |
| 125 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.34456782 |
| 126 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.33627862 |
| 127 | Insulin resistance_Homo sapiens_hsa04931 | 0.33075299 |
| 128 | Sulfur relay system_Homo sapiens_hsa04122 | 0.32879636 |
| 129 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.32367091 |
| 130 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.31988400 |
| 131 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.31889655 |
| 132 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31571954 |
| 133 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30215517 |
| 134 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.29717151 |
| 135 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.27685357 |
| 136 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.26550346 |
| 137 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.26549036 |
| 138 | Melanogenesis_Homo sapiens_hsa04916 | 0.26177224 |
| 139 | Gap junction_Homo sapiens_hsa04540 | 0.25631436 |
| 140 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.25621558 |
| 141 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.25171349 |
| 142 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.24588739 |
| 143 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.24102158 |
| 144 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.23001601 |
| 145 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.20181705 |
| 146 | Salivary secretion_Homo sapiens_hsa04970 | 0.18030648 |
| 147 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.17907462 |
| 148 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.17673393 |
| 149 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.17533938 |
| 150 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.16725843 |

